Sugi Predict

Sugi Predict / Compounds / SCHEMBL741713

SCHEMBL741713

SCHEMBL741713

O=[N+]([O-])c1cc([N+](=O)O)ccc1-[n+]1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ ATM Q13315 1/20 0.51
▸ ALDH1A1 P00352 4/20 0.41
▸ GPR35 Q9HC97 3/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CES2 O00748 1/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ TDP1 Q9NUW8 3/20 0.39
▸ HIF1A Q16665 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10444521 0.98 NPC1 (0.50) NPC1RAB9AATMALDH1A1GPR35
SCHEMBL741714 0.89 NPC1 (0.62) NPC1RAB9AATMALDH1A1GPR35
Hydrochloric Acid SCHEMBL10444520 0.87 NPC1 (0.61) NPC1RAB9AATMALDH1A1GPR35
Hydrochloric Acid SCHEMBL6131224 0.87 NPC1 (0.65) NPC1RAB9AATMALDH1A1GPR35
Hydrochloric Acid SCHEMBL31173710 0.87 NPC1 (0.65) NPC1RAB9AATMALDH1A1GPR35
SCHEMBL5156780 0.85 NPC1 (0.56) NPC1RAB9AATMALDH1A1GPR35
Thiocyanic Acid SCHEMBL6501837 0.81 NPC1 (0.54) NPC1RAB9AATMALDH1A1GPR35
SCHEMBL13648647 0.77 RAB9A (0.64) NPC1RAB9AATMALDH1A1GPR35
SCHEMBL29618182 0.77 RAB9A (0.64) NPC1RAB9AATMALDH1A1GPR35
Bisphenol A SCHEMBL8417556 0.76 NPC1 (0.47) NPC1RAB9AATMALDH1A1GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115155548-B Preparation method and application of pyridinium functionalized chitosan adsorbent 浙江农林大学 2024-03-08 — — CN claimed
CN-117412957-A Ionic cyclic nitroxyl radical oligomers 威斯康星州男校友研究基金会 2024-01-16 — — CN claimed
EP-4298090-A1 IONIC CYCLIC NITROXYL RADICAL OLIGOMERS Wisconsin Alumni Research Foundation (US) 2024-01-03 — — EP claimed
CN-116688719-A Low temperature CO 2 Method for quickly synthesizing raw material of separation carbon molecular sieve membrane 苏州魔纳新材料科技有限公司 2023-09-05 — — CN claimed
CN-115155548-A Preparation method and application of pyridinium functionalized chitosan adsorbent 浙江农林大学 2022-10-11 — — CN claimed
EP-0117196-B1 DERIVATIVES OF N-IMINOPYRIDINIUM BETAINES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS PROVESAN S.A. (CH) 1986-07-30 — — EP claimed
EP-0117196-A1 Derivatives of N-iminopyridinium betaines, their preparation and their use as medicaments PROVESAN S.A. (CH) 1984-08-29 — — EP claimed
JP-9263705-A — — None — — JP disclosed
US-20260118757-A1 RADIATION-SENSITIVE RESIST COMPOSITION AND PATTERN FORMATION METHOD USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-04-30 — — US disclosed
US-20260100415-A1 IONIC CYCLIC NITROXYL RADICAL OLIGOMERS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2026-04-09 — — US disclosed
US-12525646-B2 Ionic cyclic nitroxyl radical oligomers WISCONSIN ALUMINI RESEARCH FOUNDATION (US) 2026-01-13 — — US disclosed
CN-115155548-B Preparation method and application of pyridinium functionalized chitosan adsorbent 浙江农林大学 2024-03-08 — — CN disclosed
CN-115155548-B Preparation method and application of pyridinium functionalized chitosan adsorbent 浙江农林大学 2024-03-08 — — CN disclosed
US-5451494-A Photographic elements containing acyl substituted oxonol dyes EASTMAN KODAK COMPANY (US) 1995-09-19 — — US disclosed
CN-1105355-A Modlar design and synthesis of aminimide-containing molecules ARQULE PARTNERS L P (US) 1995-07-19 — — CN disclosed
WO-1995018186-A1 MODULAR DESIGN AND SYNTHESIS OF AMINIMIDE CONTAINING MOLECULES ARQULE PARTNERS, L.P. (US) 1995-07-06 — — WO disclosed
US-4871844-A ANTIREFLECTIVE LAYERS FOR PHOTORESISTS EASTMAN KODAK COMPANY (US) 1989-10-03 — — US disclosed
US-4668606-A Positive photoresist with antireflection coating having thermal stability EASTMAN KODAK COMPANY (US) 1987-05-26 — — US disclosed
EP-0117196-B1 DERIVATIVES OF N-IMINOPYRIDINIUM BETAINES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS PROVESAN S.A. (CH) 1986-07-30 — — EP disclosed
EP-0117196-A1 Derivatives of N-iminopyridinium betaines, their preparation and their use as medicaments PROVESAN S.A. (CH) 1984-08-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260118757-A1 RADIATION-SENSITIVE RESIST COMPOSITION AND PATTERN FORMATION METHOD USING THE SAME SLC39A14, HCN4, SLC11A2 NPC1 1328/4885RAB9A 815/4885ATM 26/4885
US-20260100415-A1 IONIC CYCLIC NITROXYL RADICAL OLIGOMERS NOX4, NOX1, CYBB NPC1 3981/4885RAB9A 1798/4885ATM 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.